DG(20:3(8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/0:0)

Metabolite details

Identifier

JDIBHXLLYJNLGX-YWTQTYENSA-N

InChI Key

JDIBHXLLYJNLGX-YWTQTYENSA-N

IUPAC name

Preferred name

DG(20:3(8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/0:0)

INN name

—

Synonym

(2S)-1-hydroxy-3-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyloxy]propan-2-yl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate

ChEBI

CHEBI:89803

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Effect of L-carnitine administration on lipid and metabolite content in sheep infraspinatus muscle after tendon release
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.

Observed in differential profiles

• Control_16.6_months_vs_Treatment_16.6_months
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h